See also this year's filing and all EDGAR filings for this company.
PDF Report 0001354591_2018_PetLife_Pharmaceuticals_Inc.pdf
Logs
info | Minor missing amount for aggregate added to remainder | industry.us_generic | {'aggregate': 'Liabilities', 'missing_ratio': 0.5, 'aggregate_val': 1436454, 'exp_sum': 2872908, 'exp_to_value': {'LiabilitiesCurrent': 1436454, 'LiabilitiesNoncurrent': 70000, 'remainder_Liabilities': 1366454}} |
info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001354591')"} |
Graph
Absolute values for 0001354591, PetLife Pharmaceuticals Inc.
xvar | xval | |
---|---|---|
0 | LiabilitiesCurrent | 1,436,454 |
1 | LiabilitiesNoncurrent | 70,000 |
2 | remainder_Liabilities | -70,000 |
3 | AssetsCurrent | 55,004 |
4 | PropertyPlantAndEquipmentNet | 0 |
5 | IntangibleAssets | 0 |
6 | AssetsNoncurrent | 0 |
7 | remainder_Assets | 0 |
8 | CostOfRevenue | 0 |
9 | SellingGeneralAndAdministrativeExpense | 0 |
10 | remainder_Expenses | 23,045,250 |
11 | remainder_Revenues | 0 |
12 | remainder_NetIncome | -211,600 |
13 | remainder_ComprehensiveNetIncome | 0 |
yvar | yval | |
---|---|---|
0 | Liabilities | 1,436,454 |
1 | Assets | 55,004 |
2 | Expenses | 23,045,250 |
3 | Revenues | 0 |
4 | StockholdersEquity | -1,381,450 |
5 | NetIncome | -23,256,850 |
6 | ComprehensiveNetIncome | -23,256,850 |
7 | BaseVar | 85,865,800 |
8 | EconomicCapitalRatio | -231 |